238 related articles for article (PubMed ID: 23066319)
1. Graft-versus-host disease after liver transplantation: a comprehensive literature review.
Akbulut S; Yilmaz M; Yilmaz S
World J Gastroenterol; 2012 Oct; 18(37):5240-8. PubMed ID: 23066319
[TBL] [Abstract][Full Text] [Related]
2. Graft-versus-host disease following liver transplantation: A systematic review of literature.
Kneifel F; Vogel T; Bormann E; Becker F; Houben P; Flammang I; Slepecka P; Eichelmann AK; Brockmann JG; Pascher A
Hepatol Commun; 2023 Oct; 7(10):. PubMed ID: 37755878
[TBL] [Abstract][Full Text] [Related]
3. Graft Versus Host Disease After Liver Transplantation in Adults: A Case series, Review of Literature, and an Approach to Management.
Murali AR; Chandra S; Stewart Z; Blazar BR; Farooq U; Ince MN; Dunkelberg J
Transplantation; 2016 Dec; 100(12):2661-2670. PubMed ID: 27495762
[TBL] [Abstract][Full Text] [Related]
4. Graft-versus-Host Disease after Liver Transplantation: A Single-Center Case Series.
Elsiesy H; Ibrahim A; Selim K; Al Sebayel M; Broering D; Al Hamoudi W; Al Arieh R; Abaalkhail F
Ann Transplant; 2015 Jul; 20():397-401. PubMed ID: 26169190
[TBL] [Abstract][Full Text] [Related]
5. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
6. Rash and pancytopenia as initial manifestations of acute graft-versus-host disease after liver transplantation.
Whalen JG; Jukic DM; English JC
J Am Acad Dermatol; 2005 May; 52(5):908-12. PubMed ID: 15858489
[TBL] [Abstract][Full Text] [Related]
7. Minimizing tacrolimus decreases the risk of new-onset diabetes mellitus after liver transplantation.
Song JL; Gao W; Zhong Y; Yan LN; Yang JY; Wen TF; Li B; Wang WT; Wu H; Xu MQ; Chen ZY; Wei YG; Jiang L; Yang J
World J Gastroenterol; 2016 Feb; 22(6):2133-41. PubMed ID: 26877618
[TBL] [Abstract][Full Text] [Related]
8. [Graft versus host disease after liver transplantation: a report of 3 cases].
Liang TB; Tang XF; Zheng SS; Lu AW; Wang WL; Shen Y; Zhang M; Meng XQ
Zhonghua Yi Xue Za Zhi; 2004 May; 84(10):826-9. PubMed ID: 15200885
[TBL] [Abstract][Full Text] [Related]
9. Abatacept use in graft-versus-host disease after orthotopic liver transplantation: a case report.
Elfeki MA; Genco PV; Pungpapong S; Nakhleh RE; Nguyen JH; Harnois DM
Transplant Proc; 2014 Sep; 46(7):2422-5. PubMed ID: 25242798
[TBL] [Abstract][Full Text] [Related]
10. Incidence and Risk Factors for Fatal Graft-versus-host Disease After Liver Transplantation.
Kitajima T; Henry M; Ivanics T; Yeddula S; Collins K; Rizzari M; Yoshida A; Abouljoud MS; Nagai S; Moonka D
Transplantation; 2021 Dec; 105(12):2571-2578. PubMed ID: 33449608
[TBL] [Abstract][Full Text] [Related]
11. Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label, multicentre, phase 3 trial.
Walker I; Panzarella T; Couban S; Couture F; Devins G; Elemary M; Gallagher G; Kerr H; Kuruvilla J; Lee SJ; Moore J; Nevill T; Popradi G; Roy J; Schultz KR; Szwajcer D; Toze C; Foley R;
Lancet Haematol; 2020 Feb; 7(2):e100-e111. PubMed ID: 31958417
[TBL] [Abstract][Full Text] [Related]
12. Liver transplant-associated graft-versus-host disease.
Smith DM; Agura E; Netto G; Collins R; Levy M; Goldstein R; Christensen L; Baker J; Altrabulsi B; Osowski L; McCormack J; Fichtel L; Dawson DB; Domiati-Saad R; Stone M; Klintmalm G
Transplantation; 2003 Jan; 75(1):118-26. PubMed ID: 12544883
[TBL] [Abstract][Full Text] [Related]
13. Monitoring systemic donor lymphocyte macrochimerism to aid the diagnosis of graft-versus-host disease after liver transplantation.
Taylor AL; Gibbs P; Sudhindran S; Key T; Goodman RS; Morgan CH; Watson CJ; Delriviere L; Alexander GJ; Jamieson NV; Bradley JA; Taylor CJ
Transplantation; 2004 Feb; 77(3):441-6. PubMed ID: 14966423
[TBL] [Abstract][Full Text] [Related]
14. Liver Graft-Versus-Host Disease is associated with poor survival among allogeneic hematopoietic stem cell transplant recipients.
Modi D; Ye JC; Surapaneni M; Singh V; Chen W; Jang H; Deol A; Ayash L; Alavi A; Ratanatharathorn V; Uberti JP
Am J Hematol; 2019 Oct; 94(10):1072-1080. PubMed ID: 31292984
[TBL] [Abstract][Full Text] [Related]
15. How I diagnose and treat acute graft-versus-host disease after solid organ transplantation.
Cooper JP; Abkowitz JL
Blood; 2023 Mar; 141(10):1136-1146. PubMed ID: 36395067
[TBL] [Abstract][Full Text] [Related]
16. Longterm results of liver transplantation from donation after circulatory death.
Blok JJ; Detry O; Putter H; Rogiers X; Porte RJ; van Hoek B; Pirenne J; Metselaar HJ; Lerut JP; Ysebaert DK; Lucidi V; Troisi RI; Samuel U; den Dulk AC; Ringers J; Braat AE;
Liver Transpl; 2016 Aug; 22(8):1107-14. PubMed ID: 27028896
[TBL] [Abstract][Full Text] [Related]
17. Donor statin treatment protects against severe acute graft-versus-host disease after related allogeneic hematopoietic cell transplantation.
Rotta M; Storer BE; Storb RF; Martin PJ; Heimfeld S; Peffer A; Maloney DG; Deeg HJ; Sandmaier BM; Appelbaum FR; Mielcarek M
Blood; 2010 Feb; 115(6):1288-95. PubMed ID: 19965630
[TBL] [Abstract][Full Text] [Related]
18. Chronic graft-versus-host disease after liver transplantation: a case report.
Yilmaz M; Ozdemir F; Akbulut S; Ersan V; Koc C; Koc S; Yilmaz S
Transplant Proc; 2012; 44(6):1751-3. PubMed ID: 22841262
[TBL] [Abstract][Full Text] [Related]
19. [Graft-vs.-host reaction: a severe complication after orthotopic liver transplantation].
Neumann U; Knoop M; Langrehr JM; Kaisers U; Bechstein WO; Blumhardt G; Lobeck H; Riess H; Neuhaus P
Zentralbl Chir; 1995; 120(6):478-81. PubMed ID: 7639037
[TBL] [Abstract][Full Text] [Related]
20. Treatment of graft-versus-host disease with mesenchymal cells as a complication of a liver transplantation.
Mora L; Alegre F; Rifón JJ; Martí P; Herrero JI
Rev Esp Enferm Dig; 2018 Nov; 110(11):734-736. PubMed ID: 30284904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
